InvestorsHub Logo
Followers 30
Posts 2777
Boards Moderated 3
Alias Born 10/24/2015

Re: None

Thursday, 03/18/2021 5:23:37 PM

Thursday, March 18, 2021 5:23:37 PM

Post# of 977
On April 28, they plan to hold an R&D Day, at which they will:

Provide a data update for TTI-622 and TTI-621, including data for the 18 mg/kg and 2 mg/kg dose cohorts, respectively.

Announce key strategic priorities in terms of target indications and drug combinations across hematologic malignancies and solid tumours.

Outline clinical development plan and clinical studies to be initiated this year.